Bengaluru, India

Lakshmi Mundkur

This inventor holds 17 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Therapeutic Compositions. Top assignees: Sami Labs Limited, Sami-Sabinsa Group Limited. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshmi Mundkur. Retrieved from https://idiyas.com/inventor/lakshmi-mundkur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nephrotoxicity Management
Receptor Targeting
Chronic Inflammation
Extracellular Metabolites
Metabolic Syndrome
Anti-Pollution Effects
Weight Loss
Hypomelanotic Conditions
Hyperglycemia
Probiotic Composition
Telomerase Enhancement
Liver Protection
17 patents (USPTO):Explore Patents

Title: Lakshmi Mundkur: A Pioneer in Innovation

Introduction

Lakshmi Mundkur, an accomplished inventor based in Bengaluru, India, holds an impressive portfolio of 17 patents. She has made significant contributions to the field of biochemistry, focusing on compositions that address critical health issues. Her work reflects a commitment to innovation and the betterment of healthcare solutions.

Latest Patents

Among her latest inventions, Lakshmi has developed compositions for the management of acute nephrotoxicity. This particular composition is enriched with various forms of curcumin, including 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin, and 10-50% w/w curcumin. The potential of this mixture encompasses the management of nephrotoxicity in mammals, showcasing her dedication to creating impactful health solutions.

In addition, she has also disclosed compositions targeting the receptor for advanced glycation end-products (RAGE) in chronic inflammatory conditions. This invention highlights the use of enriched bisdemethoxycurcumin at levels not less than 20% w/w, alongside β-amyrin palmitate, facilitating management of chronic inflammation in subjects. These inventions represent her innovative thinking and dedication to addressing significant health challenges.

Career Highlights

Lakshmi has built her career through her association with prominent organizations such as Sami Labs Limited and the Sami-Sabinsa Group Limited. Her work in these companies has reinforced her status as a leader in the field of health sciences and innovation.

Collaborations

Throughout her career, Lakshmi has collaborated with notable professionals like Kalyanam Nagabhushanam and Muhammed Majeed. These partnerships demonstrate her ability to work effectively within teams, contributing to the advancement of scientific research and development.

Conclusion

Lakshmi Mundkur embodies the spirit of innovation, with a focus on addressing complex health issues through her patented compositions. Her ongoing contributions are paving the way for advancements in medical treatments, emphasizing the importance of research and collaboration in the realm of invention. As she continues her work, the impact of her innovations will undoubtedly extend to numerous individuals seeking effective health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…